BlackRock’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$97.9M Sell
10,546,379
-1,466,018
-12% -$13.6M ﹤0.01% 2040
2025
Q1
$88.1M Buy
12,012,397
+165,910
+1% +$1.22M ﹤0.01% 2056
2024
Q4
$101M Buy
11,846,487
+492,323
+4% +$4.2M ﹤0.01% 2058
2024
Q3
$98.8M Sell
11,354,164
-166,162
-1% -$1.45M ﹤0.01% 2067
2024
Q2
$78.8M Buy
11,520,326
+3,456,623
+43% +$23.6M ﹤0.01% 2150
2024
Q1
$73.4M Buy
8,063,703
+2,302,170
+40% +$20.9M ﹤0.01% 2206
2023
Q4
$25.7M Buy
5,761,533
+417,980
+8% +$1.86M ﹤0.01% 2812
2023
Q3
$16.8M Buy
5,343,553
+80,633
+2% +$253K ﹤0.01% 2994
2023
Q2
$27.2M Buy
5,262,920
+344,611
+7% +$1.78M ﹤0.01% 2786
2023
Q1
$25.9M Sell
4,918,309
-34,428
-0.7% -$181K ﹤0.01% 2785
2022
Q4
$13.9M Buy
4,952,737
+148,776
+3% +$418K ﹤0.01% 3161
2022
Q3
$19.9M Buy
4,803,961
+8,358
+0.2% +$34.7K ﹤0.01% 2983
2022
Q2
$19.3M Sell
4,795,603
-273,718
-5% -$1.1M ﹤0.01% 3047
2022
Q1
$25.1M Sell
5,069,321
-53,514
-1% -$265K ﹤0.01% 2960
2021
Q4
$35.7M Buy
5,122,835
+150,777
+3% +$1.05M ﹤0.01% 2856
2021
Q3
$49.7M Sell
4,972,058
-7,554
-0.2% -$75.5K ﹤0.01% 2636
2021
Q2
$70.6M Sell
4,979,612
-887,450
-15% -$12.6M ﹤0.01% 2440
2021
Q1
$96.3M Buy
5,867,062
+354,798
+6% +$5.82M ﹤0.01% 2195
2020
Q4
$114M Buy
5,512,264
+1,428,200
+35% +$29.6M ﹤0.01% 1986
2020
Q3
$31.1M Buy
4,084,064
+466,439
+13% +$3.55M ﹤0.01% 2536
2020
Q2
$30.1M Buy
3,617,625
+756,696
+26% +$6.3M ﹤0.01% 2537
2020
Q1
$14.2M Buy
2,860,929
+31,285
+1% +$155K ﹤0.01% 2754
2019
Q4
$11.2M Sell
2,829,644
-243,630
-8% -$962K ﹤0.01% 3152
2019
Q3
$9.34M Buy
3,073,274
+132,529
+5% +$403K ﹤0.01% 3207
2019
Q2
$12.9M Buy
2,940,745
+97,433
+3% +$429K ﹤0.01% 3063
2019
Q1
$11.3M Buy
2,843,312
+50,560
+2% +$201K ﹤0.01% 3035
2018
Q4
$11.1M Buy
2,792,752
+500,489
+22% +$1.99M ﹤0.01% 3012
2018
Q3
$15.8M Buy
2,292,263
+326,381
+17% +$2.25M ﹤0.01% 2972
2018
Q2
$13.3M Buy
1,965,882
+269,270
+16% +$1.82M ﹤0.01% 3071
2018
Q1
$11M Buy
1,696,612
+278,035
+20% +$1.81M ﹤0.01% 3059
2017
Q4
$6.31M Buy
1,418,577
+11,293
+0.8% +$50.2K ﹤0.01% 3318
2017
Q3
$8.7M Buy
1,407,284
+27,184
+2% +$168K ﹤0.01% 3196
2017
Q2
$12.8M Buy
1,380,100
+89,355
+7% +$828K ﹤0.01% 3000
2017
Q1
$12M Buy
1,290,745
+1,288,196
+50,537% +$12M ﹤0.01% 3006
2016
Q4
$22K Buy
2,549
+1,381
+118% +$11.9K ﹤0.01% 3169
2016
Q3
$8K Hold
1,168
﹤0.01% 3374
2016
Q2
$6K Buy
1,168
+178
+18% +$914 ﹤0.01% 3451
2016
Q1
$9K Buy
990
+668
+207% +$6.07K ﹤0.01% 3149
2015
Q4
$3K Hold
322
﹤0.01% 3230
2015
Q3
$5K Hold
322
﹤0.01% 2991
2015
Q2
$7K Buy
+322
New +$7K ﹤0.01% 2946